ACNE-MAX Gel

What is ACNE-MAX

ACNE-MAX is a fixed-dose, topical dermatological preparation that combines the lincosamide antibiotic Clindamycin (as phosphate) 1 % with the retinoid Tretinoin 0.025–0.05 % in an anhydrous, water-miscible gel base. It is supplied in a 30 g lacquer-lined aluminium tube with a screw cap to protect the light-sensitive retinoid component.

• Therapeutic class: Topical anti-acne agent with dual antimicrobial and comedolytic action.
• Primary indication: Mild-to-moderate inflammatory acne vulgaris with papules, pustules, and comedones.
• Secondary benefits: Helps fade post-inflammatory hyper-pigmentation and improves overall skin texture with long-term use.
• Regulatory status: Prescription-only medicine (Rx) in most jurisdictions; pregnancy category C.
• Key advantage: Delivers complementary mechanisms in a single nightly application, simplifying multi-step regimens and enhancing adherence.
• Onset of action: Early reduction in inflammatory lesions may be observed within 2 weeks; full cosmetic benefit typically develops after 8–12 weeks of consistent application.
• Who may benefit: Adolescents and adults (≥12 yrs) who have failed over-the-counter benzoyl peroxide or monotherapy retinoids.
• Who should avoid: Patients with active regional enteritis, ulcerative colitis, antibiotic-associated colitis history, or known hypersensitivity to clindamycin, lincomycin, tretinoin, or excipient components.
• Pharmaceutical profile: Non-comedogenic, alcohol-free polysiloxane base designed for rapid cutaneous absorption and minimal residue, suitable for oily or combination skin.
• Patient counselling pearls: Explain that transient erythema, dryness, or peeling during the first 2–4 weeks is common—a sign of retinoid activity, not an allergic reaction.

How to use ACNE-MAX

Correct technique maximises efficacy and mitigates irritation. The routine should be incorporated into evening skin care, allowing at least 30 minutes between washing and application unless directed otherwise.

1. Cleanse: Gently wash the affected areas with a mild, fragrance-free cleanser; pat dry. Avoid medicated or abrasive scrubs.
2. Wait period: Allow skin to dry for 20–30 minutes to reduce trans-epidermal water loss–enhanced retinoid penetration, which can heighten irritation.
3. Apply a pea-sized amount: Dispense roughly 0.5 g (pea size) onto a fingertip. Dab onto the forehead, each cheek, chin, and nose; gently spread into a thin, invisible film.
4. Spot treat if needed: For isolated inflammatory lesions, a pinpoint application may be used in addition to the full-face layer; never occlude with dressings.
5. Avoid sensitive zones: Keep clear of eyes, lips, nostrils, and mucous membranes; wash hands immediately after use.
6. Moisturiser buffer: In very sensitive skin, apply a light non-comedogenic moisturiser 10 minutes before the gel (“retinoid sandwich method”) to reduce stinging.
7. Daytime photoprotection: Broad-spectrum SPF 30 + sunscreen is mandatory every morning; tretinoin increases photosensitivity even on cloudy days.
8. Concurrent products: Limit concomitant astringents, alcohol-based toners, benzoyl peroxide, or salicylic acid unless advised by a dermatologist. Apply other prescription topicals in separate time-slots to avoid inactivation.
9. Missed dose: Skip and resume the next evening; do not “double up.”
10. Treatment duration: Re-evaluate progress after 10–12 weeks. Maintenance may continue with alternate-night application or monotherapy retinoid per physician discretion.

Mode of Action ACNE-MAX

ACNE-MAX provides a synergistic two-pronged approach, targeting both the Propionibacterium acnes (now Cutibacterium acnes) bacterial colonisation and the faulty follicular keratinisation that underpins acne pathophysiology.

• Clindamycin 1 %
  • Binds the 50 S ribosomal subunit in C. acnes, inhibiting peptide chain initiation and translocation, thus halting bacterial protein synthesis.
  • Reduces free-fatty-acid production in sebum by suppressing bacterial lipases, indirectly lowering follicular irritation.
  • Possesses anti-inflammatory properties by down-regulating cytokines (IL-1, TNF-α), curbing papular and pustular flares.
• Tretinoin 0.025–0.05 %
  • Acts as an agonist at nuclear RAR-γ receptors in basal keratinocytes, promoting orderly desquamation and preventing microcomedone formation (the acne “seed”).
  • Increases mitotic activity and accelerates turnover of follicular epithelial cells, expelling comedonal plugs.
  • Enhances dermal collagen synthesis and angiogenesis, improving scar texture and pigmentation long term.
  • Normalises sebum composition, rendering the follicular milieu less hospitable to bacterial overgrowth.

Synergy: By unblocking the follicular duct, tretinoin enables deeper penetration of clindamycin, while the antibiotic dampens inflammation that could otherwise be exacerbated by the retinoid “purge.” The combined effect shortens time to lesion clearance and reduces emergent antibiotic resistance compared with clindamycin monotherapy.

ACNE-MAX Interactions ACNE-MAX

Although applied topically, systemic absorption—especially of clindamycin—can be clinically relevant. Evaluate the full medication list, including over-the-counter products and cosmetics.

• Topical benzoyl peroxide: May chemically oxidise tretinoin, rendering it inactive. If co-prescribed, use benzoyl peroxide in the morning and ACNE-MAX at night, or alternate-day scheduling.
• Erythromycin or other topical macrolides: Competitive binding to the same ribosomal site can lead to cross-resistance; avoid concurrent use.
• Systemic neuromuscular blocking agents (e.g., pancuronium): Clindamycin may potentiate their effect, increasing risk of prolonged respiratory depression during surgery. Notify the anaesthetist if patient is using ACNE-MAX regularly.
• Photosensitisers (thiazides, fluoroquinolones, tetracyclines, St John’s wort): Additive phototoxicity with tretinoin; reinforce rigorous sun protection or consider alternative agents.
• Keratolytics (salicylic acid >2 %, resorcinol, sulfur): Combined use heightens cumulative irritation and peeling. Introduce with caution, spacing applications by ≥12 hours.
• Systemic retinoids (isotretinoin): Theoretically increases risk of additive mucocutaneous dryness and scarring; most guidelines advise suspending topical retinoids during isotretinoin courses.
• Oral antibiotics of the lincosamide/macrolide class: Concomitant use may foster resistant flora; prioritise non-overlapping antibiotic families if systemic therapy is required.
• Hormonal contraceptives: No direct pharmacokinetic interaction, but counsel that severe vomiting/diarrhoea from antibiotic -associated colitis (a rare topical outcome) could impair oral contraceptive absorption.

Dosage of ACNE-MAX

Dosage is expressed in terms of frequency, quantity, and surface area. The standard adult and adolescent regimen is a once-daily, night-time application of a pea-sized amount to the entire face. Total weekly dose therefore approximates 3.5 g of gel, containing 35 mg clindamycin and 0.88–1.75 mg tretinoin, well below systemic antibiotic thresholds.

• Initial dosing: 1 × nightly for 6–8 weeks.
• Maintenance: After clinical clearance, reduce to 3–4 nights per week or switch to plain tretinoin, based on relapse history.
• Paediatric use (<12 yrs): Safety not established; use only under dermatologist supervision.
• Elderly: No dose adjustment required; limited data on rosacea-prone mature skin.
• Renal/hepatic impairment: Negligible systemic exposure; no adjustment, but monitor for antibiotic-associated colitis symptoms.
• Maximum safe area: Face and truncal acne may be treated if skin tolerates; do not exceed 10 % body surface area without medical review.
• Over-application risks: More frequent/thicker use does not speed results and sharply increases erythema, desquamation, and antibiotic resistance. If excessive irritation occurs, withhold for 1–2 days, reintroduce every second night, and gradually escalate.
• Accidental ocular exposure: Rinse with lukewarm water × 5 minutes; seek ophthalmic care if persistent irritation.
• Therapy discontinuation: If no improvement after 12 weeks, reassess diagnosis, adherence, and consider adjunct systemic therapy.

Possible side effects of ACNE-MAX

Most adverse events are cutaneous, dose-dependent, and reversible upon dose modification or discontinuation.

• Very common (>10 %)
  • Erythema, dryness, peeling, pruritus, mild stinging (retinoid effect; peaks at weeks 2–4, then subsides).
• Common (1–10 %)
  • Transient worsening of acne (“retinoid purge”).
  • Photosensitivity – exaggerated sunburn.
  • Oiliness paradoxically in early treatment due to barrier disruption.
• Uncommon (0.1–1 %)
  • Contact dermatitis (excipient sensitivity).
  • Perioral dermatitis if applied too close to mouth folds.
  • Hypo- or hyper-pigmentation in darker Fitzpatrick skin types when sun-exposed during active inflammation.
• Rare (<0.1 %)
  • Clostridioides difficile colitis presenting with abdominal cramps and diarrhoea (systemic clindamycin absorption); discontinue immediately and refer.
  • Severe photosensitisation with blistering.
  • Allergic urticaria or anaphylactoid reactions.

Management tips: Institute a gentle cleanser-moisturiser routine, consider short-course topical hydrocortisone 0.5–1 % for severe irritant contact dermatitis, and reinforce strict photoprotection. Report any persistent gastrointestinal symptoms or extensive rash to a healthcare professional promptly.

ACNE-MAX Contraindications ACNE-MAX

• Hypersensitivity: Documented allergy to clindamycin, lincomycin, tretinoin, or formulation excipients (e.g., parabens).
• History of antibiotic-associated colitis: Including pseudomembranous or Crohn-like colitis; topical absorption can trigger recurrence.
• Pregnancy: Category C; systemic retinoids are teratogenic and topical data are insufficient. Use only if potential benefit justifies risk – usually alternative therapies are preferred.
• Lactation: Avoid application to chest to prevent infant oral exposure; otherwise considered low risk with proper use.
• Eczema or seborrhoeic dermatitis-flared skin: Exacerbates barrier disruption and stinging.
• Sunburn or windburn: Postpone use until skin fully recovers.
• Concomitant photosensitising conditions: Lupus erythematosus, xeroderma pigmentosum.
• Age under 12 years: Safety and efficacy not established.

Storage of ACNE-MAX

• Temperature: Store below 25 °C (77 °F); avoid freezing. Elevated heat degrades tretinoin and increases clindamycin hydrolysis.
• Light protection: Keep tube tightly closed in original carton; tretinoin is photo-labile, losing potency with visible light.
• Humidity: Do not store in bathroom cabinets; high humidity can alter gel viscosity and promote microbial contamination if cap is left open.
• Cap hygiene: Wipe nozzle after each use to prevent crusting; replace cap firmly to maintain an airtight seal.
• Shelf-life: 24 months unopened; once opened, discard after 3 months even if product remains—potency progressively declines.
• Keep out of reach: Store beyond the sight and reach of children to prevent accidental ocular ingestion.
• Disposal: Do not flush or pour down drains; return unused/expired gel to a pharmacy take-back program or follow local regulations for medicinal waste.

Tip: For travel, place the tube inside an insulated pouch if ambient temperatures may exceed 30 °C (e.g., car glove compartments, beach bags).